high revenue growth, high recurring income, high margin, low churn rate, low incremental cost.
performing like a tech company.
very tricky question.
Bell Potter showed us their calculations. PE eventually comes down if they continue this growth.
- Forums
- ASX - By Stock
- BIO
- Ann: Q1 FY25 Revenue Guidance
Ann: Q1 FY25 Revenue Guidance, page-38
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
64.5¢ |
Change
-0.010(1.53%) |
Mkt cap ! $141.3M |
Open | High | Low | Value | Volume |
65.5¢ | 66.5¢ | 62.5¢ | $294.3K | 455.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13298 | 64.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.0¢ | 3298 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13298 | 0.640 |
3 | 6822 | 0.635 |
10 | 67729 | 0.630 |
2 | 24620 | 0.625 |
1 | 50000 | 0.620 |
Price($) | Vol. | No. |
---|---|---|
0.660 | 3298 | 1 |
0.665 | 3298 | 1 |
0.670 | 34520 | 3 |
0.695 | 15000 | 2 |
0.700 | 40384 | 2 |
Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online